Nutex Health Inc (NUTX) Stock Forecast & Price Target
Nutex Health Inc · NASDAQ
$148.32+2.45 (+1.68%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Nutex Health Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets span $205.00 to $290.00, a moderate spread. The average target of $243.33 sits 64% above the current $148.32. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $5.02 next quarter toward $23.03 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Nutex Health Inc.
As of Jul, 3 of 3 firms rate NUTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NUTX EPS & revenue forecast
EPS · NEXT QUARTER
$5.02
Range $2.97 – $6.17 · 5 analysts · -35% YoY
Next period, 5 analysts expect Nutex Health Inc to earn $5.02 a share (range $2.97 – $6.17), versus $7.76 a year earlier. Full-year consensus is $21.52, growing to $23.03 the year after.
REVENUE · NEXT QUARTER
$219.0M
Range $211.0M – $229.4M · 5 analysts · -18% YoY
Revenue is expected to reach $219.0M (range $211.0M – $229.4M), -18.2% year-over-year. Full-year consensus is $880.4M, rising to $969.2M next year.
Top analysts covering Nutex Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NUTX.
#1
BS
Bill Sutherland
Benchmark · Rank #52
Buy
$300.00+102.3% to target
Overall win rate
44%
+ Follow
#2
Anthony Vendetti
Maxim Group · Rank #281
Buy
$205.00+38.2% to target
Overall win rate
30%
+ Follow
#3
AS
Anderson Schock
B. Riley Securities
Buy
$290.00+95.5% to target
Coverage
—
+ Follow
#4
BH
Ben Haynor
Lake Street
Buy
$235.00+58.4% to target
Coverage
—
+ Follow
NUTX stock forecast FAQ
What is NUTX's average 12-month price target?+
The 3 analysts with a live target average $243.33 for Nutex Health Inc over the next 12 months, ranging from a $290.00 high to a $205.00 low.
Is NUTX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NUTX?+
The Street-high target is $290.00 (B. Riley Securities), and the Street-low is $205.00 (Maxim Group). The average of all 3 active targets is $243.33.
How many Wall Street analysts cover NUTX?+
3 analysts have an active rating on Nutex Health Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering NUTX?+
Among analysts who currently cover NUTX, Bill Sutherland of Benchmark has the strongest overall Quantellect track record (Rank #52). Their current call is Buy with a $300.00 target.
What is Nutex Health Inc's projected EPS for next quarter?+
The consensus estimate is $5.02 per share (range $2.97 – $6.17) across 5 analysts. Full-year EPS is projected at $21.52, rising to $23.03 the following year.
How much revenue is Nutex Health Inc expected to report next quarter?+
Consensus revenue is $219.0M (range $211.0M – $229.4M). Full-year revenue is projected at $880.4M, growing to $969.2M next year.
Have analysts been upgrading or downgrading NUTX lately?+
As of Jul, 3 of 3 firms rate NUTX a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NUTX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
